How FDA currently makes decisions on clinical studies
Author:
Affiliation:
1. Office of Medical Policy, Center for Drug Evaluation and Research, FDA, 5600 Fishers Lane, Rockville, MD 20857, USA;
Publisher
SAGE Publications
Subject
Pharmacology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1191/1740774505cn097oa
Reference6 articles.
1. Effects of Enalapril on Mortality in Severe Congestive Heart Failure
2. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
3. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
4. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
5. Effect of Carvedilol on Survival in Severe Chronic Heart Failure
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients;Therapies;2022-10
2. Pilot testing the effectiveness of whether a survey-driven tablet-based intervention increased willingness of Black women to attend to an initial PrEP clinic visit: The protocol for the pilot randomized controlled trial design and methods;Contemporary Clinical Trials Communications;2022-10
3. Facilitating treatment initiation and reproductive care postpartum to prevent substance-exposed pregnancies: A randomized bayesian pilot trial;Drug and Alcohol Dependence;2022-10
4. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial;Nicotine & Tobacco Research;2021-04-08
5. The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations;Statistics in Biopharmaceutical Research;2020-06-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3